[Insulin requirements of patients with initial manifestations and decompensation of diabetes mellitus]. 1989

M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko

Altogether 100 children suffering from insulin-dependent diabetes mellitus were examined. Analysis of insulin requirement was performed in children with the first disease manifestation and in those with varying disease standing with regard to the type of insulin preparations used. According to the clinical observations, mono-component insulin preparations turned out absolutely superior in the attainment of diabetic process compensation in children with a comparatively low insulin requirement in the course of the treatment of the first disease manifestation and insulin requirement appreciably rose with the increase of the disease standing or superaddition of intercurrent diseases.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
January 1995, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
March 1971, Michigan medicine,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
October 2022, Journal of diabetes and its complications,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
January 1983, Problemy endokrinologii,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
February 2008, Bulletin of experimental biology and medicine,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
June 1981, The New England journal of medicine,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
September 2019, World journal of diabetes,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
January 1955, A.M.A. American journal of diseases of children,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
January 1951, Omnia therapeutica,
M I Martynova, and L V Sapelkina, and V F Piliutik, and E A Terent'eva, and E O Doroshenko
September 1973, Obstetrics and gynecology,
Copied contents to your clipboard!